You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Medicines Discovery Catapult and SMi gain cancer biomarker funding

SMi and the Medicines Discovery Catapult (MDC) have secured a biomedical catalyst (BMC) grant to establish a new approach to detect cancer biomarkers.